IMNN stock · AAPL stock · Lician Pro · $19.99/mo or $149/yr

IMNN vs AAPL · rev $500.0K vs P/E 39, rev $416.16B

Imunon Inc (IMNN) versus Apple Inc (AAPL) — a side-by-side from cached financials, not a winner call.

Imunon Inc (IMNN) is a biotechnology company listed on US.

Apple Inc (AAPL) is a consumer electronics company listed on US. It is led by Timothy D. Cook.

Latest reported IMNN revenue for 2022-12-31 was $500.0K. Net income was -$35.9M. IMNN currently screens at market cap $9.2M.

Latest reported AAPL revenue for 2025-09-27 was $416.16B. Net income was $112.01B. Revenue was up 6.4% from 2024-09-28 to 2025-09-27. AAPL currently screens at market cap $3.83T and trailing P/E 39.4.

IMNN currently screens at market cap $9.2M. AAPL currently screens at market cap $3.83T and trailing P/E 39.4.

Not investment advice. Open the IMNN and AAPL stock pages for the full models.

Basic comparison

Price, market cap, and trailing P/E stay on this page.

IMNN vs AAPL
MetricIMNNAAPL
Price$1.02$343.46
Market cap$9.2M$3.83T
Trailing P/E—39.4

Deeper peer metrics

Net income and multi-year revenue growth are the peek. More peer metrics open below. This block stops at the labels.

More peer metrics

Operating margin, EPS, free cash flow, and gross margin are on Pro.

Unlock deeper peer metrics

IMNN vs AAPL comparison FAQ

What is IMNN's market cap?

Imunon Inc (IMNN) currently screens at market cap $9.2M.

What is AAPL's market cap?

Apple Inc (AAPL) currently screens at market cap $3.83T.

What is IMNN's latest revenue?

Latest reported IMNN revenue for 2022-12-31 was $500.0K.

What is AAPL's P/E ratio?

Apple Inc (AAPL) screens at trailing P/E 39.4.

What is IMNN's net income?

Net income was -$35.9M for Imunon Inc (IMNN).

What is AAPL's latest revenue?

Latest reported AAPL revenue for 2025-09-27 was $416.16B.

What is AAPL's net income?

Net income was $112.01B for Apple Inc (AAPL).

Where is the IMNN vs AAPL comparison listed?

The cached IMNN vs AAPL comparison is listed at https://lician.com/compare/imnn-vs-aapl.

Not investment advice.

Popular Stock Comparisons